Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 45,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
The Research Scientist is responsible for investigating and implementing the technical and clinical vision of the advanced technology group. The scientist will also research and investigate disruptive technical and clinical opportunities including developing clinical models of efficacy. He/she will be responsible for the tactical implementation of the program and projects within the group. Lastly, he/she will also be responsible for assisting in defining market opportunities.